33336877|t|An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum.
33336877|a|INTRODUCTION: This study examines the utility of a multipanel of cerebrospinal fluid (CSF) biomarkers complementing Alzheimer's disease (AD) biomarkers in a clinical research sample. We compared biomarkers across groups defined by clinical diagnosis and pTau181 /Abeta42 status (+/-) and explored their value in predicting cognition. METHODS: CSF biomarkers amyloid beta (Abeta)42 , pTau181 , tTau, Abeta40 , neurogranin, neurofilament light (NfL), alpha-synuclein, glial fibrillary acidic protein (GFAP), chitinase-3-like protein 1 (YKL-40), soluble triggering receptor expressed on myeloid cells 2 (sTREM2), S100 calcium binding protein B (S100B), and interleukin 6 (IL6), were measured with the NeuroToolKit (NTK) for 720 adults ages 40 to 93 years (mean age = 63.9 years, standard deviation [SD] = 9.0; 50 with dementia; 54 with mild cognitive impairment [MCI], 616 unimpaired). RESULTS: Neurodegeneration and glial activation biomarkers were elevated in pTau181 /Abeta42 + MCI/dementia participants relative to all pTau181 /Abeta42 - participants. Neurodegeneration biomarkers increased with clinical severity among pTau181 /Abeta42 + participants and predicted worse cognitive performance. Glial activation biomarkers were unrelated to cognitive performance. DISCUSSION: The NTK contains promising markers that improve the pathophysiological characterization of AD. Neurodegeneration biomarkers beyond tTau improved statistical prediction of cognition and disease stages.
33336877	62	81	Alzheimer's disease	Disease	MESH:D000544
33336877	235	254	Alzheimer's disease	Disease	MESH:D000544
33336877	256	258	AD	Disease	MESH:D000544
33336877	382	389	Abeta42	Gene	351
33336877	477	499	amyloid beta (Abeta)42	Gene	351
33336877	528	539	neurogranin	Gene	4900
33336877	541	560	neurofilament light	Gene	4747
33336877	562	565	NfL	Gene	4747
33336877	568	583	alpha-synuclein	Gene	6622
33336877	585	616	glial fibrillary acidic protein	Gene	2670
33336877	618	622	GFAP	Gene	2670
33336877	625	651	chitinase-3-like protein 1	Gene	1116
33336877	653	659	YKL-40	Gene	1116
33336877	729	759	S100 calcium binding protein B	Gene	6285
33336877	761	766	S100B	Gene	6285
33336877	773	786	interleukin 6	Gene	3569
33336877	788	791	IL6	Gene	3569
33336877	934	942	dementia	Disease	MESH:D003704
33336877	957	977	cognitive impairment	Disease	MESH:D003072
33336877	979	982	MCI	Disease	
33336877	1087	1094	Abeta42	Gene	351
33336877	1097	1100	MCI	Disease	
33336877	1101	1109	dementia	Disease	MESH:D003704
33336877	1148	1155	Abeta42	Gene	351
33336877	1249	1256	Abeta42	Gene	351
33336877	1487	1489	AD	Disease	MESH:D000544
33336877	Association	MESH:D003704	351

